Page |
||||
1 |
||||
18 |
||||
21 |
||||
24 |
||||
69 |
||||
70 |
||||
71 |
||||
81 |
||||
82 |
||||
86 |
||||
95 |
||||
97 |
||||
100 |
||||
101 |
||||
104 |
||||
105 |
||||
106 |
||||
108 |
||||
121 |
||||
123 |
||||
133 |
||||
135 |
||||
137 |
||||
141 |
||||
142 |
||||
144 |
||||
145 |
||||
146 |
||||
147 |
• | The “ Fund ,” “ we ,” “ us ,” and “ our ” refer to Carlyle Credit Income Fund, a Delaware statutory trust; and is registered under the Investment Company Act of 1940, as amended (the “ 1940 Act ”), as a non-diversified, closed-end management investment company. |
• | The “ Adviser ” refers to Carlyle Global Credit Investment Management L.L.C. (“ CGCIM SEC-registered investment adviser. |
• | The “ Administrator ” refers to SS&C Technologies, Inc. |
• | “ Risk-adjusted returns ” refers to the profile of expected asset returns across a range of potential macroeconomic scenarios, and does not imply that a particular strategy or investment should be considered low-risk. |
• | proactive sourcing and identification of investment opportunities; |
• | utilization of the Adviser’s methodical investment analysis and due diligence process; |
• | active involvement at the CLO structuring and formation stage; and |
• | taking, in many instances, significant stakes in CLO equity and junior debt tranches. |
• | Carlyle’s well-established sponsor, bank and lending relationships cultivated over 30+ years, including ~1,000 lending relationships across the firm. |
• | Scale of capital with over $146 billion under management in Carlyle’s Global Credit group and 230+ dedicated credit investment professionals. |
• | A broad network of dealer, investor, and manager relationships that Carlyle has developed during its 20+-year track record managing CLOs. |
• | Integrated efforts with cross-platform sourcing capabilities and referrals from both internal and external Carlyle networks. |
• | Ability to leverage OneCarlyle platform 1 with nearly 700 origination and underwriting resources and global knowledge base across Global Credit and Private Equity. |
• | number of borrowers underlying each CLO; |
• | industry type of a CLO’s underlying borrowers; |
• | number and investment style of CLO collateral managers; and |
• | CLO vintage period. |
1 |
The OneCarlyle platform consists of Carlyle’s global network of professionals, senior advisors, portfolio company resources, and industry contacts. Within the firm, the platform includes 1,000 Investor Services professionals who are dedicated resources to Carlyle’s limited partners. Additionally, Carlyle’s Global Credit business operates its three business segments, Liquid Credit, Private Credit and Real Assets Credit, in an integrated manner which Carlyle believes provides significant competitive advantages through shared information, resources and investment capabilities. |
• | CLO-Specific Risks |
time of investment and may produce disputes with the issuer or unexpected investment results. Changes in the collateral held by a CLO may cause payments on the instruments the Fund holds to be reduced, either temporarily or permanently. |
• | General Risks of Investing in CLOs and Other Structured Debt Securities . CLOs and other structured finance securities are generally backed by a pool of credit-related assets that serve as collateral. Accordingly, CLO and structured finance securities present risks similar to those of other types of credit investments, including default (credit), interest rate and prepayment risks. In addition, CLOs and other structured finance securities are often governed by a complex series of legal documents and contracts, which increases the risk of dispute over the interpretation and enforceability of such documents relative to other types of investments. |
• | Subordinated Securities . CLO equity and junior debt securities are subordinated to more senior tranches of CLO debt. CLO equity and junior debt securities are subject to increased risks of default relative to the holders of superior priority interests in the same CLO. In addition, at the time of issuance, CLO equity securities are under-collateralized in that the face amount of the CLO debt and CLO equity of a CLO at inception exceed its total assets. The Fund will typically be in a subordinated or first loss position with respect to realized losses on the underlying assets held by the CLOs in which we are invested. |
• | High Yield Investment Risk . The CLO equity and junior debt securities are typically rated below investment grade, or in the case of CLO equity securities unrated, and are therefore considered “higher yield” or “junk” securities and are considered speculative with respect to timely payment of interest and repayment of principal. The senior secured loans and other credit-related assets underlying CLOs are also typically higher yield investments. Investing in CLO equity and junior debt securities and other high yield investments involves greater credit and liquidity risk than investment grade obligations, which may adversely impact the Fund’s performance. |
• | Default Risk . The Fund will be subject to risks associated with defaults on an underlying asset held by a CLO. |
• | A default and any resulting loss as well as other losses on an underlying asset held by a CLO may reduce the fair value of our corresponding CLO investment. A wide range of factors could adversely affect the ability of the borrower of an underlying asset to make interest or other payments on that asset. To the extent that actual defaults and losses on the collateral of an investment exceed the level of defaults and losses factored into its purchase price, the value of the anticipated return from the investment will be reduced. The more deeply subordinated the tranche of securities in which we invest, the greater the risk of loss upon a default. For example, CLO equity is the most subordinated tranche within a CLO and is therefore subject to the greatest risk of loss resulting from defaults on the CLO’s collateral, whether due to bankruptcy or otherwise. Any defaults and losses in excess of expected default rates and loss model inputs will have a negative impact on the fair value of our investments, will reduce the cash flows that the Fund receives from its investments, adversely affect the fair value of the Fund’s assets and could adversely impact the Fund’s ability to pay dividends. Furthermore, the holders of the junior equity and debt tranches typically have limited rights with respect to decisions made with respect to collateral following an event of default on a CLO. In some cases, the senior most class of notes can elect to liquidate the collateral even if the expected proceeds are not expected to be able to pay in full all classes of notes. The Fund could experience a complete loss of its investment in such a scenario. |
• | In addition, the collateral of CLOs may require substantial workout negotiations or restructuring in the event of a default or liquidation. Any such workout or restructuring is likely to lead to a substantial reduction in the interest rate of such asset and/or a substantial write-down or write-off |
of all or a portion the principal of such asset. Any such reduction in interest rates or principal will negatively affect the fair value of the Fund’s portfolio. |
• | Prepayment Risk . The assets underlying the CLO securities are subject to prepayment by the underlying corporate borrowers. In addition, the CLO securities and related investments are subject to prepayment risk. If the Fund or a CLO collateral manager is unable to reinvest prepaid amounts in a new investment with an expected rate of return at least equal to that of the investment repaid, the Fund’s investment performance will be adversely impacted. |
• | Non-Diversification Risknon-diversified investment company under the 1940 Act and expects to hold a narrower range of investments than a diversified fund under the 1940 Act. |
• | Leverage Risk . The use of leverage, whether directly or indirectly through investments such as CLO equity or junior debt securities that inherently involve leverage, may magnify our risk of loss. CLO equity or junior debt securities are very highly leveraged (with CLO equity securities typically being leveraged ten times), and therefore the CLO securities in which we invest are subject to a higher degree of loss since the use of leverage magnifies losses. |
• | Credit Risk . If (1) a CLO in which we invest, (2) an underlying asset of any such CLO or (3) any other type of credit investment in our portfolio declines in price or fails to pay interest or principal when due because the issuer or debtor, as the case may be, experiences a decline in its financial status, our income, NAV and/or market price would be adversely impacted. |
• | Senior Management Personnel of the Adviser . Since the Fund has no employees, it depends on the investment expertise, skill and network of business contacts of the Adviser. The Adviser evaluates, negotiates, structures, executes, monitors and services the Fund’s investments. The Fund’s future success depends to a significant extent on the continued service and coordination of the Adviser and its senior management team. The departure of any members of the Adviser’s senior management team could have a material adverse effect on the Fund’s ability to achieve its investment objective. |
• | Conflicts of Interest Risk . The Fund’s executive officers and trustees, other current and future principals of the Adviser and certain members of the Adviser’s investment committee may serve as officers, trustees or principals of other entities and affiliates of the Adviser and funds managed by the Fund’s affiliates that operate in the same or a related line of business as the Fund does. Currently, the Fund’s executive officers, as well as the other principals of the Adviser, manage other funds affiliated with Carlyle, including other existing and future affiliated BDCs and registered closed-end funds, including Carlyle Secured Lending, Inc., Carlyle Credit Solutions, Inc. and Carlyle Tactical Private Credit Fund. In addition, the Adviser’s investment team has responsibilities for sourcing and managing private debt investments for certain other investment funds and accounts. Accordingly, they have obligations to investors in those entities, the fulfillment of which may not be in the best interests of, or may be adverse to the interests of, the Fund and its Shareholders. Although the professional staff of the Adviser will devote as much time to management of the Fund as appropriate to enable the Adviser to perform its duties in accordance with the Investment Advisory Agreement, the investment professionals of the Adviser may have conflicts in allocating their time and services among the Fund, on the one hand, and investment vehicles managed by Carlyle or one or more of its affiliates on the other hand. |
• | Liquidity Risk . Generally, there is no public market for the CLO investments we target. As such, we may not be able to sell such investments quickly, or at all. If we are able to sell such investments, the prices we receive may not reflect the Adviser’s assessment of their fair value or the amount paid for such investments by us. |
• | The Adviser’s Incentive Fee Risk . The Investment Advisory Agreement entitles the Adviser to receive incentive compensation on income regardless of any capital losses. In such case, the Fund may be required to pay the Adviser incentive compensation for a fiscal quarter even if there is a decline in the |
value of the Fund’s portfolio or if the Fund incurs a net loss for that quarter. Any Incentive Fee payable by the Fund that relates to its net investment income may be computed and paid on income that may include interest that has been accrued but not yet received. If an investment defaults on a loan that is structured to provide accrued interest, it is possible that accrued interest previously included in the calculation of the Incentive Fee will become uncollectible. The Adviser is not under any obligation to reimburse the Fund for any part of the Incentive Fee it received that was based on accrued income that the Fund never received as a result of a default by an entity on the obligation that resulted in the accrual of such income, and such circumstances would result in the Fund’s paying an Incentive Fee on income it never received. The Incentive Fee payable by the Fund to the Adviser may create an incentive for it to make investments on the Fund’s behalf that are risky or more speculative than would be the case in the absence of such compensation arrangement. The way in which the Incentive Fee payable to the Adviser is determined may encourage it to use leverage to increase the return on the Fund’s investments. In addition, the fact that the Management Fee is payable based upon the Fund’s Managed Assets, which would include any borrowings for investment purposes, may encourage the Adviser to use leverage to make additional investments. Under certain circumstances, the use of leverage may increase the likelihood of default, which would disfavor Shareholders. Such a practice could result in the Fund’s investing in more speculative securities than would otherwise be in its best interests, which could result in higher investment losses, particularly during cyclical economic downturns. |
• | Portfolio Fair Value Risk . Under the 1940 Act, the Fund is required to carry its portfolio investments at market value or, if there is no readily available market value, at fair value. There is not a public market for the CLO investments we target. As a result, the Adviser values these securities at least quarterly, or more frequently as may be required from time to time, at fair value. The Adviser, as valuation designee, is responsible for the valuation of the Fund’s portfolio investments and implementing the portfolio. See “Determination of Net Asset Value |
• | Limited Investment Opportunities Risk . The market for CLO securities is more limited than the market for other credit related investments. We can offer no assurances that sufficient investment opportunities for our capital will be available. See “Determination of Net Asset Value |
• | Market Risk . The success of the Fund’s activities will be affected by general economic and market conditions, such as interest rates, availability of credit, credit defaults, inflation rates, economic uncertainty, changes in laws (including laws relating to taxation of the Fund’s investments), trade barriers, currency exchange controls, disease outbreaks, pandemics, and national and international political, environmental and socioeconomic circumstances (including wars, terrorist acts or security operations). In addition, the current U.S. political environment and the resulting uncertainties regarding actual and potential shifts in U.S. foreign investment, trade, taxation, economic, environmental and other policies under the current Administration, as well as the impact of geopolitical tension, such as a deterioration in the bilateral relationship between the U.S. and China, an escalation in conflict between Russia and Ukraine or other systemic issuer or industry-specific economic disruptions, could lead to disruption, instability and volatility in the global markets. Unfavorable economic conditions also would be expected to increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. |
• | LAFs Risk . We may invest in LAFs, which are short to medium term facilities often provided by the bank that will serve as placement agent or arranger on a CLO transaction and which acquire loans on an interim basis which are expected to form part of the portfolio of a future CLO. Investments in LAFs have risks similar to those applicable to investments in CLOs. Leverage is typically utilized in such a facility and as such the potential risk of loss will be increased for such facilities employing leverage. In the event a planned CLO is not consummated, or the loans are not eligible for purchase by the CLO, the Fund may be responsible for either holding or disposing of the loans. This could expose the Fund primarily to credit and/or mark-to-market |
• | Hedging Risk . Hedging transactions seeking to reduce risks may result in poorer overall performance than if we had not engaged in such hedging transactions, and they may also not properly hedge our risks. |
• | Foreign Currency Risk . A portion of the Fund’s investments (and the income and gains received by the Fund in respect of such investments) may be denominated in currencies other than the U.S. dollar. However, the books of the Fund will be maintained, and contributions to and distributions from the Fund will generally be made, in U.S. dollars. Accordingly, changes in foreign currency exchange rates and exchange controls may materially adversely affect the value of the investments and the other assets of the Fund. |
• | Reinvestment Risk . CLOs will typically generate cash from asset repayments and sales that may be reinvested in substitute assets, subject to compliance with applicable investment tests. If the CLO collateral manager causes the CLO to purchase substitute assets at a lower yield than those initially acquired or sale proceeds are maintained temporarily in cash, it would reduce the excess interest-related cash flow, thereby having a negative effect on the fair value of our assets and the market value of our securities. In addition, the reinvestment period for a CLO may terminate early, which would cause the holders of the CLO’s securities to receive principal payments earlier than anticipated. There can be no assurance that we will be able to reinvest such amounts in an alternative investment that provides a comparable return relative to the credit risk assumed. |
• | Interest Rate Risk . General interest rate fluctuations and changes in credit spreads may have a substantial negative impact on the Fund’s investments and investment opportunities and, accordingly, may have a material adverse effect on the Fund’s rate of return on invested capital, the Fund’s net investment income and the Fund’s NAV. |
• | Refinancing Risk . If we incur debt financing and subsequently refinance such debt, the replacement debt may be at a higher cost and on less favorable terms and conditions. If we fail to extend, refinance or replace such debt financings prior to their maturity on commercially reasonable terms, our liquidity will be lower than it would have been with the benefit of such financings, which would limit our ability to grow, and holders of our common shares would not benefit from the potential for increased returns on equity that incurring leverage creates. |
• | Risks Relating to Fund’s RIC Status . Although the Fund intends to qualify to be treated as a RIC under Subchapter M of the Code, no assurance can be given that the Fund will be able to qualify for and maintain RIC status. If the Fund qualifies as a RIC under the Code, the Fund generally will not be subject to corporate-level federal income taxes on its income and capital gains that are timely distributed (or deemed distributed) as dividends for U.S. federal income tax purposes to its shareholders. To qualify as a RIC under the Code and to be relieved of federal taxes on income and gains distributed as dividends for U.S. federal income tax purposes to the Fund’s shareholders, the Fund must, among other things, meet certain source-of-income, tax-exempt interest income, if any, and net short-term capital gains in excess of net long-term capital losses, if any. |
• | Derivatives Risk . Derivative instruments in which we may invest may be volatile and involve various risks different from, and in certain cases greater than, the risks presented by other instruments. The primary risks related to Derivative Transactions include counterparty, correlation, liquidity, leverage, volatility, OTC trading, operational and legal risks. In addition, a small investment in derivatives could have a large potential impact on our performance, effecting a form of investment leverage on our portfolio. In certain types of Derivative Transactions, we could lose the entire amount of our investment; in other types of Derivative Transactions the potential loss is theoretically unlimited. |
• | Counterparty Risk . We may be exposed to counterparty risk, which could make it difficult for us or the CLOs in which we invest to collect on obligations, thereby resulting in potentially significant losses. |
• |
Global Economy Risk . Global economies and financial markets are highly interconnected, and conditions and events in one country, region or financial market may adversely impact issuers in a different country, region or financial market. |
• |
Price Risk . Investors who buy common shares at different times will likely pay different prices. |
• |
Market Disruptions Risk . The U.S. capital markets have experienced extreme volatility and disruption following the spread of COVID-19 in the United States and the conflict between Russia and Ukraine. Disruptions in the capital markets have increased the spread between the yields realized on risk-free and higher risk securities, resulting in illiquidity in parts of the capital markets. These and future market disruptions and/or illiquidity would be expected to have an adverse effect on the Fund’s business, financial condition, results of operations and cash flows. Unfavorable economic conditions also would be expected to increase the Fund’s funding costs, limit the Fund’s access to the capital markets or result in a decision by lenders not to extend credit to the Fund. |
SHAREHOLDER TRANSACTION FEES |
||
Sales load |
% (1) | |
Offering expenses borne by the Fund |
% (2) | |
Dividend reinvestment plan expenses |
% (3) | |
Total shareholder transaction fees |
% (4) | |
ANNUAL FUND EXPENSES ( ) |
||
Management Fee |
% (5) | |
Incentive Fee payable under Investment Advisory Agreement (17.5%) |
% (6) | |
Interest payments and fees on borrowed funds |
% (7) | |
Other Expenses |
% (8) | |
Total annual fund expenses |
% (9) |
(1) | In the event that the Fund sells its securities publicly through underwriters or agents the related prospectus supplement will disclose the applicable sales load. |
(2) | In the event that the Fund sells its securities publicly through underwriters or agents the related prospectus supplement will disclose the estimated amount of total offering expenses (which may include offering expenses borne by third parties on the Fund’s behalf), the offering price and the offering expenses borne by the Fund as a percentage of the offering price. |
(3) | The expenses of administering the dividend reinvestment plan (the “DRP”) are included in “Other Expenses.” You will pay brokerage charges if you direct your broker or the DRP Plan agent to sell your Common Shares that you acquired pursuant to the DRP. See “ Dividend Reinvestment Plan |
(4) | The related prospectus supplement will disclose the offering price and the total stockholder transaction expenses as a percentage of the offering price. |
(5) | month-end value of the Fund’s Managed Assets. “Managed Assets” means the total assets of the Fund (including any assets attributable to any preferred shares or to indebtedness) minus the Fund’s liabilities other than liabilities relating to indebtedness. |
(6) | The Fund shall pay CGCIM an Incentive Fee calculated and payable quarterly in arrears based upon the Fund’s “pre-incentive fee net investment income” for the immediately preceding quarter, and is subject to a hurdle rate, expressed as a rate of return on the Fund’s net assets, equal to 2.00% per quarter (or an annualized hurdle rate of 8.00%), subject to a “catch-up” feature. For this purpose, “pre-incentive fee net investment income” means interest income, dividend income, income generated from original issue discounts, payment-in-kind pre-incentive fee net investment income, the calculation methodology will look through total return swaps as if the Fund owned the referenced assets directly. As a result, the Fund’s pre-incentive fee net investment income includes net interest, if any, associated with a derivative or swap, which is the difference between (a) the interest income and transaction fees related to the reference assets and (b) all interest and other expenses paid by the Fund to the derivative or swap counterparty. Net assets means the total assets of the Fund minus the Fund’s liabilities. For purposes of the Incentive Fee, net |
assets are calculated for the relevant quarter as the weighted average of the net asset value of the Fund as of the first business day of each month therein. The weighted average net asset value shall be calculated for each month by multiplying the net asset value as of the beginning of the first business day of the month times the number of days in that month, divided by the number of days in the applicable calendar quarter. |
• | No Incentive Fee is payable to CGCIM if the Fund’s pre-incentive fee net investment income, expressed as a percentage of the Fund’s net assets in respect of the relevant calendar quarter, does not exceed the quarterly hurdle rate of 2.00%; |
• | 100% of the portion of the Fund’s pre-incentive fee net investment income that exceeds the hurdle rate but is less than or equal to 2.4242% (the “catch-up”) is payable to CGCIM if the Fund’s pre-incentive fee net investment income, expressed as a percentage of the Fund’s net assets in respect of the relevant calendar quarter, exceeds the hurdle rate but is less than or equal to 2.4242% (9.6968% annualized). The “catch-up” provision is intended to provide CGCIM. |
• | with an incentive fee of 17.5% on all of the Fund’s pre-incentive fee net investment income when the Fund’s pre-incentive fee net investment income reaches 2.4242% of net assets; and |
• | 17.5% of the portion of the Fund’s pre-incentive fee net investment income that exceeds the “catch-up” is payable to CGCIM if the Fund’s pre-incentive fee net investment income, expressed as a percentage of the Fund’s net assets in respect of the relevant calendar quarter, exceeds 2.4242% (9.6968 annualized). As a result, once the hurdle rate is reached and the catch-up is achieved, 17.5% of all the Fund’s pre-incentive fee net investment income thereafter is allocated to CGCIM. |
(7) | The Fund may issue preferred shares or debt securities. The above figure assumes an aggregate of $25 million of preferred shares with an interest rate of 8.25% per annum, and $ 25 million of debt securities with an interest rate of 8.00% per annum. In the event that the Fund were to issue preferred shares or debt securities, the Fund’s borrowing costs, and correspondingly its total annual expenses, including, in the case of such preferred shares, the base management fee as a percentage of the Fund’s net assets attributable to common shares, would increase. |
(8) |
(9) | Estimated. |
Example - |
1 Year |
3 Years |
5 Years |
10 Years |
||||||||||||
You would pay the following expenses on a $1,000 investment, assuming a 5% annual return |
$ |
$ |
$ |
$ |
Proxy Statement (1) |
Prospectus (2) |
|||||||
ANNUAL FUND EXPENSES ( |
||||||||
Management Fee (3) |
% |
% | ||||||
Incentive Fee payable under Investment Advisory Agreement (17.5%) (4) |
% |
% | ||||||
Interest payments and fees on borrowed funds (5) |
% |
% | ||||||
Other Expenses (6) |
% |
% | ||||||
Total annual fund expenses |
% |
% |
(1) |
The proxy statement provided pro forma figures based on the Fund’s most recent fiscal year (i.e., the fiscal year ended September 30, 2022) assuming the new Investment Advisory Agreement had been in place for such fiscal year. |
(2) |
This prospectus provides figures based on annualized estimates for the three-month period ending December 31, 2023 (i.e., annualized estimates for the fiscal year ending September 30, 2024). |
(3) |
(4) |
The difference in the estimated incentive fee as a percentage of net assets between the proxy statement and this prospectus is due to the proxy statement using historical financial information that would have resulted in no incentive fee being payable had the new Investment Advisory Agreement been in effect during such period. The estimated incentive fee in this prospectus is based on estimates using annualized estimates for the next fiscal year (i.e., the fiscal year ending September 30, 2024) under the Fund’s new investment strategy and existing portfolio following the portfolio sale in connection with closing the Transaction, and CGCIM is expected to be paid an incentive fee going forward. |
(5) |
The difference in estimated interest payments and fees on borrowed funds between the proxy statement and this prospectus is due to the Fund’s minimal leverage for the fiscal year ended September 30, 2022 and the expectation that the Fund will use higher leverage in the next fiscal year ending September 30, 2024. |
(6) |
Six Months Ended March 31, 2023 (Unaudited) |
Year Ended September 30, 2022 |
Year Ended September 30, 2021 |
Year Ended September 30, 2020 |
Year Ended September 30, 2019 |
Year Ended September 30, 2018 |
|||||||||||||||||||
Net Asset Value, Beginning of Year/Period: |
$ | 10.39 | $ | 11.69 | $ | 12.05 | $ | 12.71 | $ | 12.23 | $ | 12.34 | ||||||||||||
From Operations: |
||||||||||||||||||||||||
Net investment income (a) |
0.20 | 0.50 | 0.42 | 0.36 | 0.30 | 0.43 | ||||||||||||||||||
Net gain (loss) from investments (both realized and unrealized) |
(0.03 | ) | (0.80 | ) | 0.33 | (0.50 | ) | 0.72 | 0.06 | |||||||||||||||
Total from operations |
0.17 | (0.30 | ) | 0.75 | (0.14 | ) | 1.02 | 0.49 | ||||||||||||||||
Distributions to shareholders from: |
||||||||||||||||||||||||
Net investment income |
(0.41 | ) | (0.73 | ) | (0.89 | ) | (0.33 | ) | (0.34 | ) | (0.39 | ) | ||||||||||||
Net realized gains |
— | (0.18 | ) | (0.22 | ) | (0.19 | ) | (0.20 | ) | (0.21 | ) | |||||||||||||
Return of capital |
— | (0.09 | ) | — | — | — | — | |||||||||||||||||
Total Distributions |
(0.41 | ) | (1.00 | ) | (1.11 | ) | (0.52 | ) | (0.54 | ) | (0.60 | ) | ||||||||||||
Net Asset Value, End of Year/Period: |
$ | 10.15 | $ | 10.39 | $ | 11.69 | $ | 12.05 | $ | 12.71 | $ | 12.23 | ||||||||||||
Market Price, End of Year/Period |
$ | 9.81 | $ | 8.92 | $ | 10.49 | $ | 9.93 | $ | 10.68 | N/A | |||||||||||||
Total Return-NAV (b) |
1.70 | % (c) |
(2.77 | )% | 6.52 | % | (1.09 | )% | 8.62 | % | 4.03 | % | ||||||||||||
Total Return-Market Price (b) |
14.94 | % (c) |
(5.95 | )% | 17.59 | % | (2.99 | )% | (8.73 | )% | N/A | |||||||||||||
Ratios/Supplemental Data: |
||||||||||||||||||||||||
Net assets, end of Year/Period (in 000’s) |
$ | 105,327 | $ | 107,829 | $ | 121,324 | $ | 125,034 | $ | 131,945 | $ | 137,659 | ||||||||||||
Ratio of gross expenses to average net assets (d) |
4.01 | % (e)(f) |
3.27 | % (e) |
3.05 | % | 3.06 | % | 3.87 | % (g) |
3.03 | % (h) | ||||||||||||
Ratio of net expenses to average net assets (d) |
3.65 | % (e)(f) |
3.09 | % (e) |
2.88 | % | 2.73 | % | 3.34 | % (g) |
2.09 | % (h) | ||||||||||||
Ratio of net investment income to average net assets (d) |
3.93 | % (e)(f) |
4.53 | % (e) |
3.56 | % | 2.95 | % | 2.43 | % (g) |
3.52 | % (h) | ||||||||||||
Portfolio turnover rate |
0.49 | % (c) |
28.39 | % | 14.73 | % | 20.13 | % | 7.12 | % | 5.11 | % | ||||||||||||
Loan Outstanding, End of Year/Period (000s) |
$ | 3,482 | $ | 7,455 | $ | 1,923 | $ | 13,000 | $ | 2,355 | $ | 6,664 | ||||||||||||
Asset Coverage Ratio for Loan Outstanding (i) |
3125 | % | 1546 | % | 6409 | % | 1062 | % | 5702 | % | 2167 | % | ||||||||||||
Asset Coverage, per $1,000 Principal Amount of Loan Outstanding (i) |
$ | 31,253 | $ | 15,463 | $ | 64,090 | $ | 10,618 | $ | 53,778 | $ | 20,680 | ||||||||||||
Weighted Average Loans Outstanding (000s) (j) |
$ | 5,786 | $ | 8,051 | $ | 10,788 | $ | 9,796 | $ | 7,500 | $ | 4,500 | ||||||||||||
Weighted Average Interest Rate on Loans Outstanding |
7.69 | % | 4.50 | % | 3.75 | % | 3.79 | % | 5.14 | % | 4.69 | % |
(a) | Per share amounts are calculated using the annual average shares method, which more appropriately presents the per share data for the period. |
(b) | Total returns are historical in nature and assume changes in share price, reinvestment of dividends and capital gains distributions, if any, and excludes the effect of sales charges. Had the Adviser not waived expenses, total returns would have been lower. |
(c) | Not annualized. |
(d) | Ratio includes 0.49%, 0.41%, 0.41%, 0.48%, 0.46% and 0.24% for the period ended March 31, 2023 and the years ended September 30, 2022, 2021, 2020, 2019 and 2018, respectively, attributed to interest expenses and fees. |
(e) | Ratio includes 0.66% and 0.18% for the period ended March 31, 2023 and the year ended September 30, 2022, respectively, that attributed to extraordinary expenses that relate to the strategic alternative search. |
(f) | Annualized. |
(g) | Ratio includes 0.77% for the year ended September 30, 2019 that attributed to reorganization (NYSE listing) expenses and contested proxy expenses. |
(h) | Ratio includes 0.01% for the year ended September 30, 2018 that attributed to advisory transition expenses. |
(i) | Represents value of net assets plus the loan outstanding at the end of the period divided by the loan outstanding at the end of the period. |
(j) | Based on monthly weighted average. |
Year Ended September 30, 2017 |
Year Ended September 30, 2016 |
Year Ended September 30, 2015 |
Year Ended September 30, 2014 |
Year Ended September 30, 2013 |
||||||||||||||||
Net Asset Value, Beginning of Year |
$ | 12.49 | $ | 11.53 | $ | 11.04 | $ | 10.87 | $ | 10.58 | ||||||||||
From Operations: |
||||||||||||||||||||
Net investment income (a) |
0.39 | 0.36 | 0.41 | 0.51 | 0.50 | |||||||||||||||
Net gain (loss) from investments (both realized and unrealized) |
(0.04 | ) (b) |
1.33 | 0.56 | 0.27 | 0.28 | ||||||||||||||
Total from operations |
0.35 | 1.69 | 0.97 | 0.78 | 0.78 | |||||||||||||||
Distributions to shareholders from: |
||||||||||||||||||||
Net investment income |
(0.40 | ) | (0.38 | ) | (0.44 | ) | (0.56 | ) | (0.42 | ) | ||||||||||
Net realized gains |
(0.10 | ) | (0.35 | ) | (0.04 | ) | (0.05 | ) | (0.07 | ) | ||||||||||
Total Distributions |
(0.50 | ) | (0.73 | ) | (0.48 | ) | (0.61 | ) | (0.49 | ) | ||||||||||
Net Asset Value, End of year: |
$ | 12.34 | $ | 12.49 | $ | 11.53 | $ | 11.04 | $ | 10.87 | ||||||||||
Total Return (c) |
2.81 | % | 15.10 | % | 8.86 | % | 7.29 | % | 7.42 | % | ||||||||||
Ratios/Supplemental Data |
||||||||||||||||||||
Net assets, end of period (in 000’s) |
$ | 160,630 | $ | 182,008 | $ | 160,382 | $ | 108,610 | $ | 39,987 | ||||||||||
Ratio of gross expenses to average net assets |
2.74 | % (d)(e) |
2.95 | % (d)(e) |
2.67 | % (d)(e) |
2.32 | % (d) |
3.20 | % | ||||||||||
Ratio of net expenses to average net assets |
2.04 | % (d)(e) |
2.26 | % (d)(e) |
2.33 | % (d)(e) |
1.91 | % (d) |
1.85 | % | ||||||||||
Ratio of net investment income to average net assets |
3.24 | % (d)(e) |
2.98 | % (d)(e) |
3.54 | % (d)(e) |
4.68 | % (d) |
4.61 | % | ||||||||||
Portfolio turnover rate |
17.69 | % | 13.72 | % | 2.58 | % | 8.37 | % | 11.68 | % | ||||||||||
Loan Outstanding, End of Year (000s) |
$ | — | $ | — | $ | 13,522 | $ | 3,500 | $ | — | ||||||||||
Asset Coverage Ratio for Loan Outstanding (f) |
0 | % | 0 | % | 1286 | % | 3203 | % | 0 | % | ||||||||||
Asset Coverage, per $1,000 Principal Amount of Loan Outstanding (f) |
$ | — | $ | — | $ | 12,672 | $ | 32,031 | $ | — | ||||||||||
Weighted Average Loans Outstanding (000s) (g) |
$ | 14,368 | $ | 12,330 | $ | 12,372 | $ | 3,398 | $ | — | ||||||||||
Weighted Average Interest Rate on Loans Outstanding |
3.88 | % | 3.41 | % | 3.25 | % | 3.25 | % | 0 | % |
(a) | Per share amounts are calculated using the annual average shares method, which more appropriately presents the per share data for the period. |
(b) | The amount of net gain (loss) on investments (both realized and unrealized) per share does not accord with the amounts reported in the Statement of Operations due to timing of purchases and redemptions of Fund shares. |
(c) | Total returns are historical in nature and assume changes in share price, reinvestment of dividends and capital gains distributions, if any, and excludes the effect of sales charges. Had the Adviser not waived expenses, total returns would have been lower. |
(d) | Ratio includes 0.14%, 0.20%, 0.27% and 0.06% for the years ended September 30, 2017, 2016, 2015 and 2014, respectively, that attributed to interest expenses and fees. |
(e) | Ratio includes 0.05%, 0.21% and 0.21% for the years ended September 30, 2017, 2016 and the year ended 2015, respectively, that attributed to advisory transition expenses. |
(f) | Represents value of net assets plus the loan outstanding at the end of the period divided by the loan outstanding at the end of the period. |
(g) | Based on monthly weighted average. |
Assumed Return on Portfolio (Net of Expenses) |
(10.00)% | (5.00)% | 0.00% | 5.00% | 10.00% | |||||
Corresponding Share Total Return |
( |
( |
( |
(1) | limited liquidity and secondary market support; |
(2) | substantial marketplace volatility resulting from changes in prevailing interest rates; |
(3) | subordination to the prior claims of banks and other senior lenders; |
(4) | the operation of mandatory sinking fund or call/redemption provisions during periods of declining interest rates that could cause the CLO issuer to reinvest premature redemption proceeds in lower-yielding debt obligations; |
(5) | the possibility that earnings of the junk debt security issuer may be insufficient to meet its debt service; |
(6) | the declining creditworthiness and potential for insolvency of the issuer of such junk debt securities during periods of rising interest rates and/or economic downturn; and |
(7) | greater susceptibility to losses and real or perceived adverse economic and competitive industry conditions than higher grade securities. |
• | price and volume fluctuations in the overall stock market from time to time; |
• | investor demand for our common shares; |
• | significant volatility in the market price and trading volume of securities of registered closed-end management investment companies or other companies in our sector, which are not necessarily related to the operating performance of these companies; |
• | changes in regulatory policies or tax guidelines with respect to RICs or registered closed-end management investment companies; |
• | failure to qualify as a RIC, or the loss of RIC status; |
• | any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts; |
• | changes, or perceived changes, in the value of our portfolio investments; |
• | departures of any members of the Senior Investment Team; |
• | operating performance of companies comparable to us; or |
• | general economic conditions and trends and other external factors. |
• | issue securities or otherwise incur additional indebtedness or other obligations, including (1) any indebtedness or other obligations that would be equal in right of payment to our debt securities, (2) any indebtedness or other obligations that would be secured and therefore rank effectively senior in right of |
payment to our debt securities to the extent of the values of the assets securing such debt, (3) indebtedness of ours that is guaranteed by one or more of our subsidiaries and which therefore would rank structurally senior to our debt securities and (4) securities, indebtedness or obligations issued or incurred by our subsidiaries that would be senior to our equity interests in our subsidiaries and therefore rank structurally senior to our debt securities with respect to the assets of our subsidiaries, in each case other than an incurrence of indebtedness or other obligation that would cause a violation of Section 18(a)(1)(A) of the 1940 Act or any successor provisions; |
• | pay distributions or dividends on, or purchase or redeem or make any payments in respect of, capital stock or other securities ranking junior in right of payment to our debt securities, other than a distribution, dividend or purchase that would cause a violation of Section 18(a)(1)(B) of the 1940 Act or any successor provisions; |
• | sell assets (other than certain limited restrictions on our ability to consolidate, merge or sell all or substantially all of our assets); |
• | enter into transactions with affiliates; |
• | create liens (including liens on the shares of our subsidiaries) or enter into sale and leaseback transactions; |
• | make investments; or |
• | create restrictions on the payment of dividends or other amounts to us from our subsidiaries. |
• | delaying, deferring or preventing a change in corporate control; |
• | impeding a merger, consolidation, takeover or other business combination involving us; or |
• | discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of us. |
(1) | the originator, sponsor or original lender will retain on an ongoing basis a material net economic interest which, in any event, shall be not less than five per cent. in the securitization, determined in accordance with Article 6 of the applicable Securitization Regulation, and has disclosed the risk retention to such Institutional Investor; |
(2) | (in the case of each EU Institutional Investor only) the originator, sponsor or securitization special purpose entity (“ SSPE |
(3) | (in the case of each UK Institutional Investor only) the originator, sponsor or SSPE: |
(i) | if established in the UK has, where applicable, made available the information required by Article 7 of the UK Securitization Regulation (the “ UK Transparency Requirements |
(ii) | if established in a country other than the UK, where applicable, made available information which is substantially the same as that which it would have made available under the UK Transparency Requirements if it had been established in the UK, and has done so with such frequency and modalities as are substantially the same as those with which it would have made information available under the UK Transparency Requirements if it had been established in the UK; and |
(4) | in the case of each Institutional Investor, where the originator or original lender either (i) is not a credit institution or an investment firm (each as defined in the applicable Securitization Regulation) or (ii) is established in a third country (being (x) in respect of the EU Securitization Regulation, a country other than an EU member state, or (y) in respect of the UK Securitization Regulation, a country other than the UK), the originator or original lender grants all the credits giving rise to the underlying exposures on the basis of sound and well-defined criteria and clearly established processes for approving, amending, renewing and financing those credits and has effective systems in place to apply those criteria and processes in order to ensure that credit-granting is based on a thorough assessment of the obligor’s creditworthiness. |
• | Carlyle’s well-established sponsor, bank and lending relationships cultivated over 30+ years, including ~1,000 lending relationships across the firm. |
• | Scale of capital with over $146 billion under management in Global Credit and 230+ dedicated credit investment professionals. |
• | A broad network of dealer, investor, and manager relationships that Carlyle has developed during its 20+-year track record managing CLOs. |
• | Carlyle’s ongoing active dialogue with corporate private equity professionals for access to highly structured preferred or convertible securities that have an expected shorter duration than traditional private equity. |
• | Integrated efforts with cross-platform sourcing capabilities and referrals from both internal and external Carlyle networks. |
• | Ability to leverage OneCarlyle platform with nearly 700 origination and underwriting resources and global knowledge base across Global Credit and Private Equity. |
• | The Fund may also benefit from opportunities sourced by Carlyle investment vehicles that fall outside the scope of their respective investment mandates. |
2 |
Source: Creditflux as of March 31, 2023 inclusive of middle market CLOs. |
3 |
Source: Creditflux as of March 31, 2023 inclusive of middle market CLOs. |
• | No Incentive Fee is payable to CGCIM if the Fund’s pre-incentive fee net investment income, expressed as a percentage of the Fund’s net assets in respect of the relevant calendar quarter, does not exceed the quarterly hurdle rate of 2.00%; |
• | 100% of the portion of the Fund’s pre-incentive fee net investment income that exceeds the hurdle rate but is less than or equal to 2.4242% (the “catch-up pre-incentive fee net investment income, expressed as a percentage of the Fund’s net assets in respect of the relevant calendar quarter, exceeds the hurdle rate but is less than or equal to 2.4242% (9.6968% annualized). The “catch-up” provision is intended to provide CGCIM with an incentive fee of 17.5% on all of the Fund’s pre-incentive fee net investment income when the Fund’s pre-incentive fee net investment income reaches 2.4242% of net assets; and |
• | 17.5% of the portion of the Fund’s pre-incentive fee net investment income that exceeds the “catch-up” is payable to CGCIM if the Fund’s pre-incentive fee net investment income, expressed as a percentage of the Fund’s net assets in respect of the relevant calendar quarter, exceeds 2.4242% (9.6968% annualized). As a result, once the hurdle rate is reached and the catch-up is achieved, 17.5% of all the Fund’s pre-incentive fee net investment income thereafter is allocated to CGCIM. |
Scenarios expressed as a percentage of average Net Assets |
Scenario 1 |
Scenario 2 |
Scenario 3 |
|||||||||
Pre-incentive fee net investment income |
0.550 |
% |
2.350 |
% |
3.000 |
% | ||||||
Catch up incentive fee (maximum of 0.424%) |
— |
(0.350 |
%) |
(0.424 |
%) | |||||||
Split incentive fee (17.5% above 2.424%) |
— |
— |
(0.101 |
%) | ||||||||
Net Investment income |
0.550 |
% |
2.000 |
% |
2.475 |
% |
• | corporate, organizational and offering costs relating to offerings of the Fund’s securities; |
• | the cost of calculating the NAV of shares, including the cost of any third-party pricing or valuation services; |
• | the cost of effecting sales and repurchases of shares and other securities; |
• | the Management Fee and Incentive Fee; |
• | distribution and/or shareholder servicing fees; |
• | investment related expenses (e.g., expenses that, in the Adviser’s discretion, are related to the investment of the Fund’s assets, whether or not such investments are consummated), including, as applicable, brokerage commissions, borrowing charges on securities sold short, clearing and settlement charges, recordkeeping, interest expense, line of credit fees, dividends on securities sold but not yet purchased, margin fees, investment related travel and lodging expenses and research-related expenses; |
• | professional fees relating to investments, including expenses of consultants, investment bankers, attorneys, accountants and other experts; |
• | transfer agent, sub-transfer agent and custodial fees; |
• | fees and expenses associated with marketing and distribution efforts; |
• | federal and any state registration or notification fees; |
• | federal, state and local taxes; |
• | fees and expenses incident to qualifying and listing of the Fund’s common shares on any exchange; |
• | fees and expenses of Trustees not also serving in an executive officer capacity for the Fund or the Adviser; |
• | the costs of preparing, printing and mailing reports and other communications, including repurchase offer correspondence or similar materials, to Shareholders; |
• | fidelity bond, Trustees and officers errors and omissions liability insurance and other insurance premiums; |
• | legal expenses (including those expenses associated with preparing the Fund’s public filings, attending and preparing for Board meetings, as applicable, and generally serving as counsel to the Fund or the Independent Trustees of the Fund); |
• | external accounting expenses (including fees and disbursements and expenses related to the annual audit of the Fund and the preparation of the Fund’s tax information); |
• | any costs and expenses associated with or related to due diligence performed with respect to the Fund’s offering of its shares, including but not limited to, costs associated with or related to due diligence activities performed by, on behalf of, or for the benefit of broker-dealers, registered investment advisors and third-party due diligence providers; |
• | any and all fees, costs and expenses incurred in implementing or maintaining third-party or proprietary software tools, programs or technology for the benefit of the Fund; |
• | costs associated with reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws, including compliance with The Sarbanes-Oxley Act of 2002; |
• | the compensation of the Fund’s Chief Compliance Officer and the salary of any compliance personnel of the Adviser and its affiliates who provide compliance-related services to the Fund, provided such salary expenses are properly allocated between the Fund and other affiliates, as applicable, and any costs associated with the monitoring, testing and revision of the Fund’s compliance policies and procedures required by Rule 38a-1 under the 1940 Act; |
• | all other expenses incurred by the Fund in connection with administering the Fund’s business, including expenses by State Street for performing administrative services for the Fund, subject to the terms of the Administration Agreement; and |
• | any expenses incurred outside of the ordinary course of business, including, without limitation, costs incurred in connection with any claim, litigation, arbitration, mediation, government investigation or similar proceeding and indemnification expenses as provided for in the Fund’s organizational documents. |
Name, address (1) and year of birth |
Position to be Held with the Fund |
Term of Office and Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Number of Portfolios in Fund Complex(2) to be Overseen by Trustee |
Other Directorships Held by Nominee Trustee in Past Five Years | |||||
Mark Garbin (1951) | Trustee | Class I Board member until 2025 annual shareholder meeting – since July 2023 | Managing Principal, Coherent Capital Management LLC (since 2008) | 2 | Independent Trustee of Two Roads Shared Trust (since 2012), Forethought Variable Insurance Trust (since 2013), Northern Lights Fund Trust (since 2013), Northern Lights Variable Trust (since 2013), iCapital KKR Private Markets Fund (since 2014), Independent Director of Oak Hill Advisors Mortgage Strategies Fund (offshore), Ltd. (2015-2017), Independent Director of OHA CLO Enhanced Equity II Genpar LLP (since 2021), and Independent Trustee, Carlyle Tactical Private Credit Fund (since 2018). |
Name, address (1) and year of birth |
Position to be Held with the Fund |
Term of Office and Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Number of Portfolios in Fund Complex(2) to be Overseen by Trustee |
Other Directorships Held by Nominee Trustee in Past Five Years | |||||
Sanjeev Handa (1961) | Trustee | Class III Board member until 2024 annual shareholder meeting – since July 2023 | Managing Member, Old Orchard Lane, LLC (since 2014); Adjunct Professor, Fairfield University (since 2020) | 2 | Advisory Board Member of White Oak Partners (since 2021) and Independent Director of OHA CLO Enhanced Equity II Genpar LLP (since 2021), Independent Trustee, Carlyle Tactical Private Credit Fund (since March 2018); Board of Trustees Investment Committee Member for the Cooper Union for Advancement of Science and Art (since 2016); Board of Directors Member for the Mutual Fund Directors Forum (Since 2022); Independent Director of Fitch Ratings, Inc. (2015-2020). | |||||
Joan McCabe (1955) | Trustee | Class II Board member until 2023 annual shareholder meeting. – since July 2023 | Managing Member, JMYME, LLC (since 2020); CEO/Founder, Lipotriad LLC (2015-2019) | 2 | Elevation Brands (since 2017 to 11/2022); Sensible Organics (2017-2021); Goodwill International, Inc. (2015-2021); Gulfstream Goodwill, Inc. (since 2017; Board Chair since 2021); Gulfstream Goodwill Academy, Inc. (since 2017), Goodwill International (2015-2021) Independent Trustee Carlyle Tactical Private Credit Fund (since 2018). |
(1) | Address is c/o Carlyle Global Credit Investment Management L.L.C., One Vanderbilt Avenue, Suite 3400, New York, NY 10017. |
Name, address (1) and year of birth |
Position to be Held with the Fund |
Term of Office and Length of Time Served (2) |
Principal Occupation(s) During Past 5 Years |
Number of Portfolios in Fund Complex to be Overseen by Trustee |
Other Directorships Held by Nominee Trustee in Past Five Years | |||||
Brian Marcus (1983) |
Trustee | Class I Board member until 2025 annual shareholder meeting. – since July 2023 | Managing Director, The Carlyle Group, Inc. (Since 2021); Principal, Carlyle Group (2018 – 2020); Vice President, The Carlyle Group, Inc. (2015 – 2017) | 1 | None | |||||
Lauren Basmadjian (1979) |
Trustee | Class III Board member until 2024 annual shareholder meeting. – since July 2023 | Managing Director, The Carlyle Group, Inc. (Since 2020); Senior Portfolio Manager, Octagon Credit Investors, LLC (2001 to 2020) | 1 | None |
(1) | Address is c/o Carlyle Global Credit Investment Management L.L.C., One Vanderbilt Avenue, Suite 3400, New York, NY 10017. |
(2) | “Interested person,” as defined in the 1940 Act, of the Fund. Mr. Marcus and Ms. Basmadjian are interested persons of the Fund due to their affiliation with the Adviser. |
Name, address (1) and year of birth |
Position to be Held with the Fund |
Term of Office |
Principal Occupation(s) During Past 5 Years | |||
Lauren Basmadjian (1979) |
President, Principal Executive Officer | Indefinite Length – since July 2023 | Managing Director, The Carlyle Group, Inc. (Since 2020); Senior Portfolio Manager, Octagon Credit Investors, LLC (2001 to 2020) | |||
Nelson Joseph (1979) | Principal Financial Officer, Principal Accounting Officer and Treasurer | Indefinite Length – since July 2023 | Principal, Carlyle Group (Since 2023); Director, Apollo Global Management LLC (2016 – 2022) | |||
Joshua Lefkowitz (1974) | Secretary; Chief Legal Officer; Chief Compliance Officer | Indefinite Length – since July 2023 | Managing Director and Chief Legal Officer (Global Credit), Carlyle Group (Since 2018); Principal and Associate General Counsel, Ares Management, Ltd. (2017 – 2018); Vice President and Associate General Counsel, American Capital, Ltd. (2006 – 2017) |
(1) | Address is c/o Carlyle Global Credit Investment Management L.L.C., One Vanderbilt Avenue, Suite 3400, New York, NY 10017. |
Name of Trustee or Officer |
Dollar Range of Equity Securities in the Fund |
Aggregate Dollar Range of Equity Securities in All Registered Investment Companies Overseen by Trustee in Family of Investment Companies (1) |
||||||
Mark Gabin |
None | None | ||||||
Sanjeev Handa |
None | None | ||||||
Joan McCabe |
None | None | ||||||
Brian Marcus. |
None | None | ||||||
Lauren Basmadjian |
None | None |
(1) | Dollar ranges are as follows: None, $1–$10,000, $10,001–$50,000, $50,001–$100,000, $100,001–$500,000, $500,001–$1,000,000 or Over $1,000,000. |
Name of Trustee |
Aggregate Compensation from the Fund (1) |
|||
Interested Trustees |
||||
Brian Marcus |
None | |||
Lauren Basmadjian |
None | |||
Independent Trustees |
||||
Mark Garbin |
$40,000 | |||
Sanjeev Handa |
$45,000 | |||
Joan McCabe |
$40,000 |
(1) | Amounts shown reflect annual compensation of such Trustee, which will be prorated for the present fiscal year. |
Number of Accounts |
Assets of Accounts (in billions) |
Number of Accounts Subject to a Performance Fee |
Assets Subject to a Performance Fee (in billions) |
|||||||||||||
Lauren Basmadjian |
||||||||||||||||
Registered Investment Companies |
0 | $ | 0.00 | 0 | $ | 0 | ||||||||||
Other Pooled Investment Vehicles |
73 | $ | 37.23 | 67 | $ | 36.74 | ||||||||||
Other Accounts |
1 | $ | 0.05 | 0 | $ | 0 |
Name of Portfolio Manager |
Dollar Range of Equity Securities in the Fund (1) | |
Lauren Basmadjian |
None | |
Nishil Mehta |
None |
(1) | Dollar ranges are as follows: None, $1 – $10,000, $10,001 – $50,000, $50,001 – $100,000, $100,001 – $500,000, $500,001 – $1,000,000 and over $1,000,000. |
Closing Sales Price |
Premium (Discount) of High Sales Price to NAV (2) |
Premium (Discount) of Low Sales Price to NAV (2) |
Distributions Declared (3) |
|||||||||||||||||||||
Period |
NAV (1) |
High |
Low |
|||||||||||||||||||||
Fiscal year ending September 30, 2021 |
||||||||||||||||||||||||
First quarter |
( |
)% |
( |
)% |
0.3950 |
|||||||||||||||||||
Second quarter |
( |
)% |
( |
)% |
0.2395 |
|||||||||||||||||||
Third quarter |
( |
)% |
( |
)% |
0.2360 |
|||||||||||||||||||
Fourth quarter |
( |
)% |
( |
)% |
0.2367 |
|||||||||||||||||||
Fiscal year ending September 30, 2022 (4) |
||||||||||||||||||||||||
First quarter |
( |
)% |
( |
)% |
0.3381 |
|||||||||||||||||||
Second quarter |
( |
)% |
( |
)% |
0.2271 |
|||||||||||||||||||
Third quarter |
( |
)% |
( |
)% |
0.2194 |
|||||||||||||||||||
Fourth quarter |
( |
)% |
( |
)% |
0.2139 |
|||||||||||||||||||
Fiscal year ending September 30, 2023 (5) |
||||||||||||||||||||||||
First quarter |
( |
)% |
( |
)% |
0.2068 |
|||||||||||||||||||
Second quarter |
( |
)% |
( |
)% |
0.2050 |
|||||||||||||||||||
Third quarter |
% |
( |
)% |
0.2022 |
||||||||||||||||||||
Fourth quarter |
(1) | NAV per common share is determined as of the last day in the relevant quarter and therefore may not reflect the NAV per common share on the date of the high and low sales prices. The NAVs shown are based on outstanding common shares at the end of each period. |
(2) | Calculated as of the respective high or low closing sales price divided by the quarter end NAV. |
(3) | Represents the cash distributions (including dividends, dividends reinvested and returns of capital, if any) per common share that we have declared on our common shares in the specified quarter. Tax characteristics of distributions will vary. |
(4) | For the fiscal year ending September 30, 2022, distributions made by us were comprised, in part, of a return of capital, as calculated on a per common share basis, of $0.088 per common share. |
(5) | For the fiscal quarter ending December 31, 2022, distributions made by us were comprised, in part, of an estimated return of capital, as calculated on a per common share basis, of $0.1253 per common share. For the fiscal quarter ending March 31, 2023, distributions made by us were comprised, in part, of an estimated return of capital, as calculated on a per common share basis, of $0.0699 per common share. For the fiscal quarter ending June 30, 2023, distributions made by us were comprised, in part, of an estimated return of capital, as calculated on a per common share basis, of $0.1021 per common share. |
Title of Class |
Amount Authorized |
Amount Held By Fund |
Amount Outstanding | |||
Shares of Beneficial Interest |
shares |
* | Prior to the Closing, the Fund was authorized to issue an unlimited number of common shares, subject to a $1 billion limit on the Fund, which would represent 120,918,984 shares assuming $8.27 NAV. Under the Declaration of Trust, the Fund is authorized to issue an unlimited number of common shares and is not subject to a dollar limit on the size of the Fund. |
• | 10% or more, but less than 15% of all voting power; |
• | 15% or more, but less than 20% of all voting power; |
• | 20% or more, but less than 25% of all voting power; |
• | 25% or more, but less than 30% of all voting power; |
• | 30% or more, but less than a majority of all voting power; or |
• | a majority or more of all voting power. |
• | immediately after issuance and before any distribution is made with respect to shares, we must meet a coverage ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred shares, of at least 200%; and |
• | the holders of preferred shares must be entitled as a class to elect two trustees at all times and to elect a majority of the trustees if and for so long as dividends on the preferred shares are unpaid in an amount equal to two full years of dividends on the preferred shares. |
• | the designation and number of shares of such class or series; |
• | the rate and time at which, and the preferences and conditions under which, any dividends will be paid on shares of such class or series, as well as whether such dividends are participating or non-participating; |
• | any provisions relating to convertibility or exchangeability of the shares of such class or series, including adjustments to the conversion price of such class or series; |
• | the rights and preferences, if any, of holders of shares of such class or series upon our liquidation, dissolution or winding up of our affairs; |
• | the voting powers, if any, of the holders of shares of such class or series; |
• | any provisions relating to the redemption of the shares of such class or series; |
• | any limitations on our ability to pay dividends or make distributions on, or acquire or redeem, other securities while shares of such class or series are outstanding; |
• | any conditions or restrictions on our ability to issue additional shares of such class or series or other securities; |
• | if applicable, a discussion of certain U.S. federal income tax considerations; and |
• | any other relative powers, preferences and participating, optional or special rights of shares of such class or series, and the qualifications, limitations or restrictions thereof. |
• | the period of time the offering would remain open (which shall be open a minimum number of days such that all record holders would be eligible to participate in the offering and shall not be open longer than 120 days); |
• | the title of such subscription rights; |
• | the exercise price for such subscription rights (or method of calculation thereof); |
• | the ratio of the offering (which, in the case of transferable rights, will require a minimum of three shares to be held of record before a person is entitled to purchase an additional share); |
• | the number of such subscription rights issued to each Shareholder; |
• | the extent to which such subscription rights are transferable and the market on which they may be traded if they are transferable; |
• | if applicable, a discussion of certain U.S. federal income tax considerations applicable to the issuance or exercise of such subscription rights; |
• | the date on which the right to exercise such subscription rights shall commence, and the date on which such right shall expire (subject to any extension); |
• | the extent to which such subscription rights include an over-subscription privilege with respect to unsubscribed securities and the terms of such over-subscription privilege; |
• | any termination right we may have in connection with such subscription rights offering; and |
• | any other terms of such subscription rights, including exercise, settlement and other procedures and limitations relating to the transfer and exercise of such subscription rights. |
• | the offering fully protects shareholders preemptive rights and does not discriminate among shareholders; |
• | management uses its best efforts to ensure an adequate trading market in the rights for use by shareholders who do not exercise such rights; |
• | ratio of offering does not exceed one new share for each three rights held; and |
• | the Board makes good faith determination that the offering would result in a net benefit to existing shareholders. |
• | the designation or title of the series of debt securities; |
• | the total principal amount of the series of debt securities; |
• | the percentage of the principal amount at which the series of debt securities will be offered; |
• | the date or dates on which principal will be payable; |
• | the rate or rates (which may be either fixed or variable) and/or the method of determining such rate or rates of interest, if any; |
• | the date or dates from which any interest will accrue, or the method of determining such date or dates, and the date or dates on which any interest will be payable; |
• | the terms for redemption, extension or early repayment, if any; |
• | the currencies in which the series of debt securities are issued and payable; |
• | whether the amount of payments of principal, premium or interest, if any, on a series of debt securities will be determined with reference to an index, formula or other method (which could be based on one or more currencies, commodities, equity indices or other indices) and how these amounts will be determined; |
• | the place or places, if any, other than or in addition to the City of New York, of payment, transfer, conversion and/or exchange of the debt securities; |
• | the denominations in which the offered debt securities will be issued ; |
• | the provision for any sinking fund; |
• | any restrictive covenants; |
• | any Events of Default (as described below); |
• | whether the series of debt securities are issuable in certificated form; |
• | any provisions for defeasance or covenant defeasance; |
• | if applicable, a discussion of certain U.S. federal income tax considerations; |
• | whether and under what circumstances we will pay additional amounts in respect of any tax, assessment or governmental charge and, if so, whether we will have the option to redeem the debt securities rather than pay the additional amounts (and the terms of this option); |
• | any provisions for convertibility or exchangeability of the debt securities into or for any other securities; |
• | the listing, if any, on a securities exchange; and |
• | any other terms. |
• | how it handles securities payments and notices; |
• | whether it imposes fees or charges; |
• | how it would handle a request for the holders’ consent, if ever required; |
• | whether and how you can instruct it to send you debt securities registered in your own name so you can be a holder, if that is permitted in the future for a particular series of debt securities; |
• | how it would exercise rights under the debt securities if there were a default or other event triggering the need for holders to act to protect their interests; and |
• | if the debt securities are in book-entry form, how the depositary’s rules and procedures will affect these matters. |
• | an investor cannot cause the debt securities to be registered in his, her or its name and cannot obtain certificates for his, her or its interest in the debt securities, except in the special situations we describe below; |
• | an investor will be an indirect holder and must look to his, her or its own bank or broker for payments on the debt securities and protection of his, her or its legal rights relating to the debt securities, as we describe under “—Issuance of Securities in Registered Form” above; |
• | an investor may not be able to sell interests in the debt securities to some insurance companies and other institutions that are required by law to own their securities in non-book-entry form; |
• | an investor may not be able to pledge his, her or its interest in a global security in circumstances where certificates representing the debt securities must be delivered to the lender or other beneficiary of the pledge in order for the pledge to be effective; |
• | the depositary’s policies, which may change from time to time, will govern payments, transfers, exchanges and other matters relating to an investor’s interest in a global security. We and the trustee have no responsibility for any aspect of the depositary’s actions or for its records of ownership interests in a global security. We and the trustee also do not supervise the depositary in any way; |
• | if we redeem less than all the debt securities of a particular series being redeemed, DTC’s practice is to determine by lot the amount to be redeemed from each of its participants holding that series; |
• | an investor is required to give notice of exercise of any option to elect repayment of its debt securities, through its participant, to the applicable trustee and to deliver the related debt securities by causing its participant to transfer its interest in those debt securities, on DTC’s records, to the applicable trustee; |
• | DTC requires that those who purchase and sell interests in a global security deposited in its book-entry system use immediately available funds; your broker or bank may also require you to use immediately available funds when purchasing or selling interests in a global security; and |
• | financial institutions that participate in the depositary’s book-entry system, and through which an investor holds its interest in a global security, may also have their own policies affecting payments, notices and other matters relating to the debt securities; there may be more than one financial intermediary in the chain of ownership for an investor; we do not monitor, nor are we responsible for the actions of, any of those intermediaries. |
• | we do not pay the principal of (or premium, if any, on) a debt security of the series when due and payable, and such default is not cured within five days; |
• | we do not pay interest on a debt security of the series when due, and such default is not cured within 30 days; |
• | we do not deposit any sinking fund payment in respect of debt securities of the series on its due date, and do not cure this default within five days; |
• | we remain in breach of any other covenant with respect to debt securities of the series for 60 days after we receive a written notice of default stating we are in breach. The notice must be sent by either the trustee or holders of at least 25% of the principal amount of debt securities of the series; |
• | we file for bankruptcy or certain other events of bankruptcy, insolvency or reorganization occur and in the case of certain orders or decrees entered against us under any bankruptcy law, such order or decree remains undischarged or unstayed for a period of 90 days; |
• | on the last business day of each of twenty-four consecutive calendar months, all series of our debt securities issued under the indenture together have an asset coverage of less than 100% after giving effect to exemptive relief, if any, granted to us by the SEC; or |
• | any other Event of Default in respect of debt securities of the series described in the applicable prospectus supplement occurs. |
• | you must give the applicable trustee written notice that an Event of Default with respect to the relevant series of debt securities has occurred and remains uncured; |
• | the holders of at least 25% in principal amount of all outstanding debt securities of the relevant series must make a written request that the trustee take action because of the default and must offer the trustee reasonable indemnity, security, or both against the costs, expenses, and other liabilities of taking that action; |
• | the trustee must not have taken action for 60 days after receipt of the above notice and offer of indemnity and/or security; and |
• | the holders of a majority in principal amount of the outstanding debt securities of the relevant series must not have given the trustee a direction inconsistent with the above notice during that 60-day period. |
• | in the payment of principal, any premium or interest; or |
• | in respect of a covenant that cannot be modified or amended without the consent of each holder. |
• | where we merge out of existence or convey or transfer substantially all of our assets, the resulting entity or transferee must agree to be legally responsible for our obligations under the debt securities; |
• | immediately after the transaction, no default or Event of Default will have happened and be continuing; |
• | we must deliver certain certificates and documents to the trustee; and |
• | we must satisfy any other requirements specified in the prospectus supplement relating to a particular series of debt securities. |
• | change the stated maturity of the principal of or interest on a debt security or the terms of any sinking fund with respect to any security; |
• | reduce any amounts due on a debt security; |
• | reduce the amount of principal payable upon acceleration of the maturity of a debt security following a default; |
• | adversely affect any right of repayment at the holder’s option; |
• | change the place or currency of payment on a debt security (except as otherwise described in the prospectus or prospectus supplement); |
• | impair your right to sue for payment following the date on which such amount is due and payable; |
• | adversely affect any right to convert or exchange a debt security in accordance with its terms; |
• | reduce the percentage in principal amount of holders of debt securities whose consent is needed to modify or amend the indenture; |
• | reduce the percentage in principal amount of holders of debt securities whose consent is needed to waive compliance with certain provisions of the indenture or to waive certain defaults; and |
• | modify any other aspect of the provisions of the indenture dealing with supplemental indentures with the consent of holders, waiver of past defaults, changes to the quorum or voting requirements or the waiver of certain covenants. |
• | if the change affects only one series of debt securities, it must be approved by the holders of a majority in principal amount of that series; and |
• | if the change affects more than one series of debt securities issued under the same indenture, it must be approved by the holders of a majority in principal amount of all of the series affected by the change, with all affected series voting together as one class for this purpose. |
• | for original issue discount securities, we will use the principal amount that would be due and payable on the voting date if the maturity of these debt securities were accelerated to that date because of a default; |
• | for debt securities whose principal amount is not known (for example, because it is based on an index), we will use a special rule for that debt security described in the prospectus supplement; and |
• | for debt securities denominated in one or more foreign currencies, we will use the U.S. dollar equivalent. |
• | if the debt securities of a particular series are denominated in U.S. dollars, we must deposit in trust for the benefit of all holders of such series of debt securities a combination of cash and U.S. government or U.S. government agency notes or bonds that will generate enough cash to make interest, principal and any other payments on the debt securities on their various due dates and any mandatory sinking fund payments or analogous payments; |
• | we must deliver to the trustee a legal opinion of our counsel confirming that, under current U.S. federal income tax law, we may make the above deposit without causing you to be taxed on the debt securities any differently than if such covenant defeasance had not occurred; |
• | we must deliver to the trustee a legal opinion and officers’ certificate stating that all conditions precedent to covenant defeasance have been complied with; |
• | defeasance must not result in a breach or violation of, or result in a default under, the indenture or any of our other material agreements or instruments; and |
• | no default or event of default with respect to such debt securities shall have occurred and be continuing and no defaults or events of default related to bankruptcy, insolvency or reorganization shall occur during the next 90 days; and |
• | satisfy the conditions for covenant defeasance contained in any supplemental indentures. |
• | if the debt securities of a particular series are denominated in U.S. dollars, we must deposit in trust for the benefit of all holders of such securities a combination of money and U.S. government or U.S. government agency notes or bonds that will generate enough cash to make interest, principal and any other payments on such securities on their various due dates; |
• | we must deliver to the trustee a legal opinion confirming that there has been a change in current U.S. federal income tax law or an IRS ruling that allows us to make the above deposit without causing you to be taxed on the debt securities any differently than if such defeasance had not occurred. Under current U.S. federal income tax law, the deposit and our legal release from the debt securities would be treated as though we paid you your share of the cash and notes or bonds at the time the cash and notes or bonds were deposited in trust in exchange for your debt securities and you would recognize gain or loss on the debt securities at the time of the deposit; |
• | we must deliver to the trustee a legal opinion and officers’ certificate stating that all conditions precedent to defeasance have been complied with; |
• | defeasance must not result in a breach or violation of, or constitute a default under, of the indenture or any of our other material agreements or instruments, as applicable; |
• | no default or event of default with respect to such debt securities shall have occurred and be continuing and no defaults or events of default related to bankruptcy, insolvency or reorganization shall occur during the next 90 days; and |
• | satisfy the conditions for full defeasance contained in any supplemental indentures. |
• | an individual who is a citizen or resident of the United States; |
• | a corporation, or other entity taxable as a corporation, created or organized in or under the laws of the United States, any state thereof or the District of Columbia; |
• | an estate the income of which is subject to U.S. federal income taxation regardless of its source; or |
• | a trust if it (a) is subject to the primary supervision of a court within the United States and one or more U.S. persons have the authority to control all substantial decisions of the trust or (b) has a valid election in effect under applicable Treasury Regulations to be treated as a U.S. person. |
• | change our classification to an open-end management investment company; |
• | alter any of our fundamental policies, which are set forth below in “ — Fundamental Investment Restrictions |
• | change the nature of our business so as to cease to be an investment company. |
(1) | Borrow money, except to the extent permitted by the 1940 Act (which currently limits borrowing to no more than 33-1/3% of the value of the Fund’s total assets, including the value of the assets purchased with the proceeds of its indebtedness, if any). The Fund may borrow for investment purposes, for temporary liquidity, or to finance repurchases of its shares. |
(2) | Issue senior securities, except to the extent permitted by Section 18 of the 1940 Act (which currently limits the issuance of a class of senior securities that is indebtedness to no more than 33-1/3% of the value of the Fund’s total assets or, if the class of senior security is stock, to no more than 50% of the value of the Fund’s total assets). |
(3) | Underwrite securities of other issuers, except insofar as the Fund may be deemed an underwriter under the Securities Act of 1933, as amended (the “ Securities Act |
(4) | Invest more than 25% of the market value of its assets in the securities of companies, entities or issuers engaged in any one industry. This limitation does not apply to investment in the securities of the U.S. Government, its agencies or instrumentalities. For purposes of this restriction, an investment in a CLO, collateralized bond obligation, CDO or a swap or other derivative will be considered to be an investment in the industry (if any) of the underlying or reference security, instrument or asset. |
(5) | Purchase or sell real estate or interests in real estate. This limitation is not applicable to investments in securities that are secured by or represent interests in real estate (e.g. mortgage loans evidenced by notes or other writings defined to be a type of security). Additionally, the preceding limitation on real estate or interests in real estate does not preclude the Fund from investing in mortgage-related securities or investing in companies engaged in the real estate business or that have a significant portion of their assets in real estate (including real estate investment trusts), nor from disposing of real estate that may be acquired pursuant to a foreclosure (or equivalent procedure) upon a security interest. |
(6) | Purchase or sell commodities, commodity contracts, including commodity futures contracts, unless acquired as a result of ownership of securities or other investments, except that the Fund may invest in securities or other instruments backed by or linked to commodities, and invest in companies that are engaged in a commodities business or have a significant portion of their assets in commodities, and may invest in commodity pools and other entities that purchase and sell commodities and commodity contracts. |
(7) | Make loans to others, except (a) through the purchase of debt securities in accordance with its investment objectives and policies, including notes secured by real estate, which may be considered loans; (b) to the extent the entry into a repurchase agreement is deemed to be a loan; and (c) by loaning portfolio securities. Additionally, the preceding limitation on loans does not preclude the Fund from modifying note terms. |
(1) | Change or alter the Fund’s investment objective or 80% policy; |
(2) | Purchase securities of other investment companies, except to the extent that such purchases are permitted by applicable law, including any exemptive orders issued by the SEC; and |
(3) | Purchase any securities on margin except as may be necessary in connection with transactions described in this prospectus and except that the Fund may obtain such short-term credit as may be necessary for the clearance of purchases and sales of portfolio investments (the deposit or payment by the Fund of initial or variation margin in connection with swaps, forward contracts and financial futures contracts and options thereon is not considered the purchase of a security on margin). |
Title of class |
Name of beneficial owner* |
Amount and nature of beneficial ownership* |
Percent of class* | |||
shares of beneficial interest |
Almitas Capital LLC 1460 4th Street, Suite 300 Santa Monica, CA 90401 (1) |
546,229 |
4.68% | |||
shares of beneficial interest |
Sit Investment Associates, Inc. 3300 IDS Center 80 South Eighth Street Minneapolis, MN 55402 (2) |
573,536 |
4.92% | |||
shares of beneficial interest |
Bulldog Investors, LLC Park 80 West, 250 Pehle Avenue, Suite 708 Saddle Brook, NJ 07663 (3) |
255,724 |
2.19% | |||
shares of beneficial interest |
Thomas J. Herzfeld Advisors, Inc. 119 Washington Avenue, Suite 504 Miami Beach, FL 33139 (4) |
1,067,278 |
9.15% | |||
shares of beneficial interest |
Relative Value Partners Group, LLC 1033 Skokie Blvd., Suite 470 Northbrook, Ill 60062 (5) |
1,648,907 |
14.14% | |||
shares of beneficial interest |
CG Subsidiary Holdings L.L.C. One Vanderbilt Avenue, Suite 3400, New York, NY 10017 (6) |
4,785,628 |
41.04% |
* |
Beneficial ownership percentages based on 11,661,159 common shares outstanding as of September 22, 2023. To the extent any of the beneficial owners mentioned in the table above tender their shares in the Tender Offer, their beneficial ownership would be reduced. |
(1) | As per February 14, 2023, Schedule 13G/A filing on EDGAR. Beneficial ownership described in filing is based on sole and shared voting and investment powers. |
(2) | As per February 14, 2023, Schedule 13G filing on EDGAR. Beneficial ownership described in filing is based on shared voting and investment powers. |
(3) |
As per August 31, 2023, Schedule 13D/A filing on EDGAR. Beneficial ownership described in filing is based on sole and shared voting and investment powers of reporting persons: Bulldog Investors, LLC; Phillip Goldstein (individually and as a principal of Bulldog Investors, LLC); and Andrew Dakos (as a principal of Bulldog Investors, LLC). |
(4) |
As per August 16, 2023 Schedule 13D filing on EDGAR. Beneficial ownership described in filing is based on sole voting and investment powers. |
(5) |
As per July 17, 2023 Schedule 13D/A filing on EDGAR. Beneficial ownership described in filing is based on sole voting and investment powers. |
(6) |
As per September 14, 2023 Schedule 13D/A filing on EDGAR. CG Subsidiary Holdings L.L.C. holds more than 25% of the voting securities of the Fund and therefore may be considered a controlling person of the Fund under the 1940 Act to the extent it has the power to exercise a controlling influence over the management or policies of the Fund. CGCIM, the investment advisor of the Fund, is an indirect subsidiary of CG Subsidiary Holdings L.L.C. Accordingly, CG Subsidiary Holdings L.L.C. may be considered an affiliate of the Fund. |
• | Our Notification of Registration on Form 8-A, filed with the SEC on May 3, 2011. |
• | Our definitive proxy statement on Schedule 14A, filed with the SEC on September 1, 2022; |
• | Our Annual Report on Form N-CSR for the fiscal year ended September 30, 2022, filed with the SEC on December 13, 2022; |
• | Our Semi-Annual Report on Form N-CSRS for the period ended March 31, 2023, filed with the SEC May 30, 2023; and |
• |